The Solution For Disease FREE Health...
Prevent Alzheimer's With Natural Remedies!
World's #1 Publisher of Information About Alternative
Cancer Treatments Cancer Defeated
By Dr. Mercola
The US Food and Drug Administration (FDA) is looking to increase their
budget by $821 million next year, which would make their proposed 2014 budget
a hefty $4.7 billion.
The additional money would help the FDA improve food safety, monitor
imports and create measures to protect against chemical and biological
threats, FDA Commissioner Margaret Hamburg told Congress, outrageously noting
FDA is a true bargain among federal agencies.
This has to be one of the biggest delusions of the 21st century.This is
one bargain that is not such a good deal for Americans’ health, as the FDA is
also the federal agency responsible for a growing list of policy decisions
that favor big industry at the expense of public health.
And if their nearly $1-billion budget increase is approved, they stand to
fall even further into the drug companies’ trenches.
94 Percent of the FDA’s Budget Increase Funded by Drug Companies
Out of the extra $821 million the FDA is seeking, 94 percent, or $770
million, would come from user fees paid by the drug industry. While some of
the FDA is funded by taxpayers, most of their budget comes from such user
fees, which are paid by the drug companies to hasten the review and approval
of their products.
Industry user fees were first introduced in the early 1990s in an effort
to help speed up the FDA's approval process; prior to that, the FDA had been
funded entirely by Congress.
This is one of the main reasons why the FDA’s track record for keeping you
safely out of harm’s way has failed so miserably over the years, as user fees
allow the drug industry to have major leverage over the FDA, and that control
is continuing to increase year after year.
The FDA is even trying to have about $83 million in industry user fees
exempted from the sequester (mandatory budget cuts to federal agencies that
began in 2013), as these fees are supposed to be withheld due to the
sequestration. Yet, with a budget already surpassing the $4-billion mark, the
FDA has done little to keep Americans safe from dangerous foods and drugs.
Quietly withdrew their intent to ban low-dose antibiotics in animal
feed, allowing the spread of antibiotic-resistant super-germs linked to this
practice to continue unabated
Approved the first genetically modified plant intended for the
treatment of a human disease, opening the door for biotech companies such as
Monsanto, which also has vested interests in the pharmaceutical industry, to
design more drugs created from genetically engineered plants and/or animals.
Is considering allowing the unlabeled use of the artificial sweetener
aspartame in dairy products.
Approved a generic version of Actos the brand name for a drug used to
treat type 2 diabetes even though it is presently embroiled in thousands of
lawsuits alleging that the drug causes severe side effects including heart
failure, macular edema and bladder cancer.
Attempting to regulate stem cell procedures at a Colorado clinic, even
though the stem cells being used in the procedure come from the patient’s own
body, which means they are essentially claiming that they can regulate a part
of your body
FDA Allows Drugs to Remain on Market Despite Uncovering Fraudulent Safety Data
What do you get when the federal agency in charge of monitoring drug
safety is funded largely by the companies producing those very same drugs? A
massive conflict of interest and an agency that is more interested in serving
the drug industry than the American public.
This is not speculation; it’s been shown to be the truth, time and time
again. In 2011, the FDA found out that many studies conducted at Cetero
Research, a major drug research lab, from 2005 to 2009 were fraudulent,
involving manipulated data and tampered records. About 100 drugs were already
on the market, approved, at least in part, based on these fraudulent studies.
Yet, the FDA made no warnings to the public, instead allowing the
potentially dangerous drugs to remain on the market while it quietly ordered
re-testing to be done. In Europe, however, multiple drugs were pulled from the
market following the revelation. Even today, the FDA has never released a list
of the affected drugs, saying this would reveal trade secrets.
Unfortunately, this wasn’t an isolated case. As Scientific American and
Turns out that wasn't an anomaly: The agency's slow, secretive
response in the Cetero case mirrors how it handled an earlier instance of
scientific misconduct at another contract research organization, MDS Pharma
When the FDA found that four years’ worth of data produced by two MDS
facilities were potentially fraudulent, it again refused to post a public list
of the 217 affected drugs, some of which were already being sold. Despite
requiring re-testing of many of the medications, the FDA assured the public
that the drugs were safe an impossible truth since they were approved, in
part, based on faulty research. At least five of MDS’ senior executives later
went to work for Cetero Research.
Scientific American continued:
In January 2007, three and a half years after first finding problems
at MDS, the FDA informed drug makers that studies done by MDS between 2000
and2004 needed to be reevaluated. FDA officials told the media that 217 generic
drugs were potentially implicated, 140 of which were already approved for
The agency was unsure how many new drugs might have relied on studies
carried out by MDS, according to news accounts, so it asked the manufacturers
of every new drug approved between 2000 and 2004 -- some 900 medicines -- to
check to see if MDS had conducted any relevant tests. 2The FDA made no effort
to warn doctors or patients that it now had doubts about the data underlying
some of the drugs it had approved. Instead, the agency sounded a public 'all
The FDA Is Failing at Its Stated Mission
Now, with the FDA requesting even more money from the drug industry, it’s
likely that such egregious biases in favor of the industry are only going to
continue. They simply cannot risk biting the proverbial hand that feeds them
…The FDA's mission statement reads as follows:
"The FDA is responsible for protecting the public health by assuring
the safety, efficacy, and security of human and veterinary drugs, biological
products, medical devices, our nation's food supply, cosmetics, and products
that emit radiation. The FDA is also responsible for advancing the public
health by helping to speed innovations that make medicines and foods more
effective, safer, and more affordable; and helping the public get the
accurate, science-based information they need to use medicines and foods to
improve their health."
In 2007, a report bearing the revealing title "FDA Science and Mission at
Risk" by the Subcommittee on Science and Technology, detailed how the FDA
cannot fulfill its stated mission because:
Its scientific base has eroded and its scientific organizational
structure is weak
Its scientific workforce does not have sufficient capacity and
capability, and Its information technology (IT) infrastructure is inadequate
Furthermore, the report found that "the development of medical products
based on 'new science' cannot be adequately regulated by the FDA, and that
the agency does not have the capacity to carry out risk assessment and analysis.
Additionally, the agency's science agenda "lacks coherent structure and vision,
as well as effective coordination and prioritization."
The fact that the FDA does not have its ducks in a row, so to speak, has
sorely misplaced its priorities, and is not working to fulfill its mission is
clearly evidenced in the numerous cases where hundreds and sometimes thousands
of complaints about dangerous drugs (like Vioxx and Avandia), vaccines (like
Gardasil), and additives (like aspartame) are stubbornly ignored, while SWAT-
style teams armed to the teeth are sent to raid supplement makers, whole food
businesses, organic farmers, and raw dairies when oftentimes not a single
incidence of harm can be attributed to their products.
Hospitals Make More Money From Surgical Complications
The FDA has little incentive to change its current structure or work
harder to uncover drug dangers, lest they put billions of dollars of their
funding at risk. Likewise, a revealing new JAMA study found that major
surgical complications actually earn hospitals more money on privately insured
or Medicare-covered patients.
This isn’t exactly shocking, of course, since the more complications
suffered, the longer the hospital stay and the more associated medications,
tests and procedures that will be ordered. Hospitals are a business, after
all, and the more services used by any one patient, the more money they
Where money is concerned, a hospital therefore has no incentive to reduce
surgical errors and other medical mishaps, which may actually be a key
moneymaker for them. And, as the Health Business Blog astutely reported,
unlike most businesses, which suffer financially when mistakes occur,
hospitals get to charge you even more money to treat you for avoidable
complications or mistakes they make. Decreasing surgical complications may
therefore have adverse financial consequences for many hospitals, the
More Reason to Take Control of Your Health
Minor changes to the existing structure will not be enough to change the
current medical paradigm, which is designed to profit from your ill health. A
complete reform of the system would instead be needed, and there are powerful
forces at play that do not want this to happen.
As much as possible, be proactive in using a healthy lifestyle to support
and protect your health and, if illness does occur, use natural methods that
will allow your body to heal itself without the need for the deadly drugs
being pushed on you by the drug companies and the FDA.
Thank You Dr. Mercola
God Bless Everyone & God Bless The United States of America.
42 S. Sherwood Dr.
Belton, Tx. 76513
Post a Comment